Abstract
Objectives in improving cancer treatment can be categorized as those that improve efficacy and those that lessen morbidity.
Minimally invasive surgery seeks to decrease morbidity from surgery while maintaining at the very least equivalent efficacy. Laparoscopic method is established as a standard technique with the landmark trial of GOG LAP2.
Robotic approach further enhances the benefits of laparoscopy with similar results especially in obese women. However, randomized trials are awaited in this regard. Early case series thus far reported suggest robotic surgery for endometrial cancer is feasible.
Main advantages of robotic technology over laparoscopy include 3D vision with better camera, more flexible instruments, less conversion rate, ease of surgery, surgeon’s comfort, and shorter learning curve.
Current limitations of robotic surgery are mostly due to mechanical/energy source-related instrument problems, high cost, and longer operating time.
The extent of surgery depends on the stage and extent of disease.
Adjuvant treatment is offered based on surgical stage and adverse factors.
Chemoradiation shows promising results in high-risk and advanced-stage disease.
Systemic treatment of metastatic and relapsed disease may consist of endocrine therapy or cytotoxic chemotherapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
http://globocan.iarc.fr. Last accessed 12 July 2013.
Balasubramaniam G et al. Hospital-based study of endometrial cancer survival in Mumbai, India. Asian Pac J Cancer Prev. 2013;14(2):977–80.
Vergote I, Amant F, Timmerman D. Should we screen for endometrial cancer? Lancet Oncol. 2011;12:4–5.
Timmerman A, Opmeer BC, Khan KS, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol. 2010;116:160–7.
Clark TJ, Volt D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288:1610–21.
Pecorelli S; FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–104.
Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrialcancer: a meta analysis. Radiology. 1999;212:711–8.
Sala E, Rockall A, Kubik-Huch RA. Advances in magnetic resonance imaging of endometrial cancer. Eur Radiol. 2011;21:468–73.
Savelli L, Ceccarini M, Ludovisi M, et al. Preoperative local staging of endometrial cancer: transvaginal sonography versus magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008;31:560–8.
Paley PJ, Veljovich DS, Shah CA. Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases. Am J Obstet Gynecol. 2011;204:551e1–51e.
Benedetti PP, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy versus no lymphadenectomy in early-stage endometrial carcinoma: randomised clinical trial. J Natl Cancer Inst. 2008;100:1707–16.
ASTEC study group, Kitchener H, Swart AM, Qian A, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ATEC trial): a randomised study. Lancet. 2009;373:125–36.
Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165–72.
Wright JD, Buck AM, Shah M, et al. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27:1214–9.
Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404–11.
Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.
Blake P, Swart AM, Orton J, et al. ; ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and metaanalysis. Lancet. 2009;373:137–146.
Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816–23.
Maggi R, Lissoni A, Spina A, et al. Adjuvant chemotherapy versus radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer. 2006;95:266–71.
Susumu N, Sagae S, Udagawa Y, et al. Randomised phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol. 2008;108:226–33.
Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer—results from two randomised studies. Eur J Cancer. 2010;46:2422–31.
Randall ME, Filiaci VL, Muss H, et al. Randomised phase III trial of whole abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2006;24:36–44.
Humber CE, Tierney JF, Symonds RP, et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol. 2007;18:409–20.
Oza AM, Elit L, Tsao MS, et al. Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group. J Clin Oncol. 2011;29:3278–85.
Colombo N, McMeekin DS, Schwartz PE, et al. Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial. Br J Cancer. 2013;108:1021–6.
Fader AN, Drake RD, O’Malley DM, et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 2009;115:2119–27.
Somashekhar SP, Jaka RC, Zaveri SS. Prospective randomized study comparing robotic-assisted hysterectomy and regional lymphadenectomy with traditional laparotomy for staging of endometrial carcinoma –initial Indian experience. Indian J Surg Oncol.doi:10.1007/s13193-014-0321-8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Somashekhar, S.P. (2017). Minimally Invasive Surgery for Endometrial Cancer. In: Patni, R. (eds) Current Concepts in Endometrial Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-3108-3_7
Download citation
DOI: https://doi.org/10.1007/978-981-10-3108-3_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3107-6
Online ISBN: 978-981-10-3108-3
eBook Packages: MedicineMedicine (R0)